Janus Henderson Group’s Mereo BioPharma MREO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,290,130
Closed -$33.6M 2445
2025
Q3
$33.6M Sell
16,290,130
-1,398,462
-8% -$2.58M 0.02% 495
2025
Q2
$48.1M Sell
17,688,592
-5,046,529
-22% -$12.2M 0.02% 395
2025
Q1
$52.4M Buy
22,735,121
+5,612,558
+33% +$15.9M 0.03% 368
2024
Q4
$59.8M Buy
17,122,563
+4,776,697
+39% +$18.8M 0.03% 347
2024
Q3
$50.9M Buy
12,345,866
+4,464,984
+57% +$18.5M 0.03% 384
2024
Q2
$28.4M Buy
7,880,882
+2,760,309
+54% +$8.94M 0.02% 502
2024
Q1
$16.9M Buy
+5,120,573
New +$17.3M 0.01% 587
2021
Q1
Sell
-1,124,678
Closed -$4M 1604
2020
Q4
$4M Buy
+1,124,678
New +$2.82M ﹤0.01% 1004

Other funds holding MREO